Comparative Study Between The Effect Of Aerobic Exercises On Land and Aerobic Exercises In Water On PMS Syndrome

Effect Of Aerobic Exercises On Land Versus Aerobic Exercises In Water In The Management Of Premenstrual Syndrome In Adolescent Girls

Many girls experience premenstrual syndrome PMS which is re a group of physical, cognitive, affective, and behavioural symptoms that occur cyclically during the luteal phase of the menstrual cycle and resolve at or within a few days of the onset of menstruation. In young adolescents symptoms might particularly affect school functions, and social interactions in a negative ways in this study we will figure out the effect of 2 kinds of exercises in the management of this syndrome.

Study Overview

• Status: Recruiting
• Conditions: Premenstrual Syndrome
• Intervention / Treatment: Other: aerobic exercise on land; Other: aerobic exercise in water

Detailed Description

Fourty adolescent girls were divided randomly into two equal groups, Group (A) will consist of (20) adolescent girls age ranged from 14-17 suffering from PMS without any pathological cause they will receive an aerobic exercise on land in form of walking on the treadmill for 20 min 3 times per week for 3 months. Group (B) will consist of (20) adolescent girls age ranged from 14-17 suffering from PMS without any pathological cause they will receive an aerobic exercises in water in form of walking on the treadmill for 20 min 3 times per week for 3 months the assessment of the PMS symptoms will be done by Premenstrual distress questionnaire

• Study Type: Interventional
• Enrollment (Anticipated): 40
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: MARIAM Dr EL EBRASHY, Phd; Phone Number: +2 01001716570; Email: Mariam.elabrashi@buc.edu.eg
• Study Contact Backup: Name: hend sakr, Phd; Phone Number: +2 01003501013; Email: hend.reda@buc.edu.eg

Study Locations

• Egypt
  • Cairo, Egypt
    • Recruiting
    • Badr University
    • Contact: Mariam El Ebrashy, Phd; Phone Number: 01001716570; Email: Mariam.elabrashi@buc.edu.eg

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 14 years to 17 years (Child)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: Female

Description

Inclusion Criteria:

• All participants virgin females.
• Their age ranged from 14 to 17 years old
• their body mass index (BMI) ≥ 18 ≤ 25 kg/m2.
• They are clinically and medically stable during the study,
• they have regular menstrual cycle of 23 to 35 days and not participated any type of unusual diet during the period of the study.

Exclusion Criteria:

• All females in this study are free from: cardiopulmonary or orthopaedic problems, taking any hormonal drugs for three months at least, participating in any form of activity rather than the prescribed one in the study, any abnormality in ovulation or pelvic inflammatory diseases (PID).

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: GROUP A; will consist of (20) adolescent girls age ranged from 14-17 suffering from PMS without any pathological cause they will receive an aerobic exercise on land in form of walking on the treadmill for 20 min 3 times per week for 3 months.	Other: aerobic exercise on land; aerobic exercise on land in form of walking on the treadmill
Active Comparator: GROUP B; will consist of (20) adolescent girls age ranged from 14-17 suffering from PMS without any pathological cause they will receive an aerobic exercises in water in form of walking on the treadmill for 20 min 3 times per week for 3 months	Other: aerobic exercise in water; aerobic exercises in water in form of walking on the treadmill

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Premenstrual syndrome symptoms	PREMENSTRUAL SYNDROME QUESTIONNAIRE	3 months

Collaborators and Investigators

• Sponsor: Mariam Hossam El Ebrashy
• Investigators: Study Director: Mina Atef, Phd, Badr University

Study record dates

Study Major Dates

• Study Start (Actual): December 15, 2022
• Primary Completion (Anticipated): March 2, 2023
• Study Completion (Anticipated): April 30, 2023

Study Registration Dates

• First Submitted: December 1, 2022
• First Submitted That Met QC Criteria: December 1, 2022
• First Posted (Actual): December 9, 2022

Study Record Updates

• Last Update Posted (Estimate): January 26, 2023
• Last Update Submitted That Met QC Criteria: January 24, 2023
• Last Verified: January 1, 2023

More Information

Terms related to this study

• Keywords: premenstrual syndrome
• Additional Relevant MeSH Terms: Pathologic Processes; Disease; Menstruation Disturbances; Syndrome; Premenstrual Syndrome
• Other Study ID Numbers: 2

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No